Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-021178

CHIEF FINANCIAL OFFICER sold 18,889 shares at $32.89 ($621,259)

  • CHIEF FINANCIAL OFFICER acquired 18,889 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-08-04 Option exercise 10b5-1 +18,889 $22.89 $432,369 45,898 D: show line 1 in the form
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-08-04 Sale 10b5-1 −18,889 $32.89 $621,259 27,009 D: show line 2 in the form
Open-market sales · 18,889 sh · avg $32.89 · $621,259

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ragosa Mark CHIEF FINANCIAL OFFICER 2025-08-04 Option exercise · Share Option 10b5-1 −18,889 2,036 D: show line 3 in the form
Loading xslF345X05/form4-08062025_040802.xml…